Market Snapshot

BSE Sensex: 81332.72 1.62%
BSE 500: 36795.89 1.65%
BSE 200: 11475.13 1.74%
BSE 100: 26248.18 1.76%
BSE MidCap: 47706.67 2.12%
BSE SmallCap: 54294.35 1.00%
BSE BANKEX: 58638.77 0.86%
BSE IT: 41836.85 2.15%
Nifty 50: 24834.85 1.76%
Nifty 500: 23292.05 1.64%
Nifty 200: 14039.2 1.73%
Nifty 100: 25841.9 1.71%
Nifty Midcap 100: 57768.1 1.81%
Nifty Small 100: 18854 0.97%
Nifty IT: 40977.35 2.30%
Nifty PSU Bank: 7270.65 1.66%

News:

IndusInd Bank PAT rises to Rs ...
Cipla spurts as Q1 PAT rises 1...
Shriram Finance soars as Q1 PA...
Indus Towers spurts on buyback...
MMTC Ltd leads losers in A gro...

Unichem Laboratories Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

Invest

26 Jul 2024 | 03:59 PM

540.35

7.85 (1.47%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

42.16%

Return (1Y)

Underperformed BSE Healthcare by 6.75%
More Volatile

2.39%

Standard Deviation (1Y)

Higher than BSE Healthcare by 1.56%
Not so consistent

5/12

Months

underperformed BSE Healthcare
AxisDirect View

No View

52 Week High-Low

616

378

News & Announcements

Unichem Laboratories to table results
12 hours ago

Unichem Laboratories to table results

26 - Jul - 2024 12:00 AM | 12 hours ago

Unichem Laboratories will hold a meeting of the Board of Directors of the Company on 8 August 2024.
Powered by Capital Market - Live News
Unichem Laboratories to hold AGM
27 days ago

Unichem Laboratories to hold AGM

29 - Jun - 2024 12:00 AM | 27 days ago

Unichem Laboratories announced that the 61th Annual General Meeting (AGM) of the company will be held on 8 August 2024.
Powered by Capital Market - Live News
Unichem Lab net loss widens to Rs 129 cr in Q4
65 days ago

Unichem Lab net loss widens to Rs 129 cr in Q4

22 - May - 2024 12:00 AM | 65 days ago

Revenue from operations rose 7.36% year on year (YoY) to Rs 431.70 crore in the quarter ended 31 March 2024.
The drug maker recorded loss before exceptional item and tax of Rs 0.25 crore in Q4 FY24 as compared with loss before exceptional item and tax of Rs 13.61 crore in Q4 FY23.
The company has a provision for European commission fine as exceptional loss stood of Rs 125.62 crore in the March 2024 quarter. The exceptional loss stood at Rs 33.54 crore in Q4 FY23, due to one-time discretionary loyalty bonus.
On a full year basis, the firm posted consolidated net loss of Rs 70.47 crore in FY24 as against net loss of Rs 202.23 crore in FY23. Net sales rose 26.94% YoY to Rs 1,442.16 crore in financial year ended March 2024.
Unichem Laboratories is a pharmaceutical company. It addresses the needs of therapeutic areas like gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterials, anti-infectives and pain management.
The scrip rose 0.10% to close at Rs 561.55 on the BSE.
Powered by Capital Market - Live News

Unichem Laboratories reports consolidated net loss of Rs 129.31 crore in the March 2024 quarter

65 days ago

Price vs Volume

Stock Trivia

MF shareholding in Unichem Laboratories Ltd has increased by 3.77% since past 3 Months
FII shareholding in Unichem Laboratories Ltd has decreased by -44.9% since past 1 Year
MF shareholding in Unichem Laboratories Ltd has increased by 66.06% since past 1 Year
Promoter shareholding in Unichem Laboratories Ltd has increased by 37.87% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended			Year Ended
	Mar. 2024	Mar. 2023	% Var.	Mar. 2024	Mar. 2023	% Var.
Sales	431.70	402.10	7	1704.89	1343.02	27
OPM %	5.87	4.10	-	5.88	-3.39	-
PBDT	26.91	16.07	67	109.18	-24.35	LP
PBT	-0.25	-13.62	98	-4.06	-137.79	97
NP	-129.31	-44.27	-192	-70.47	-202.23	65

General Notifications

My Notifications

Research Notifications

Unichem Laboratories Ltd Share Price – NSE / BSE Pharmaceuticals, Small Cap

540.35 7.85 (1.47%)

News & Announcements

Price vs Volume

Stock Trivia

Unichem Laboratories Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

540.35

7.85 (1.47%)